Recce Pharmaceuticals

About Recce Pharmaceuticals

Recce Ltd is a world-leader in synthetic-polymer antibiotics. The RECCE® antibiotics have been synthesized by an extremely economic method. RECCE® antibiotics have shown in laboratory tests that they have continued activity against bacteria, including superbugs, even after repeated use. Recce is positioned to achieve milestones in both pre-clinical trials for FDA purposes, and the development of the manufacture of RECCE® 327.

YEAR FOUNDED:

2007

LEADERSHIP:

Founder: Graham JH Melrose

CFO: Peter Williams

CLINICAL TRIAL:

Please click here for clinical trial information.